Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Plos Biology
|
October 13, 2006
A signaling network for patterning of neuronal connectivity in the Drosophila brain
Mohammed Srahna, Maarten Leyssen, Ching Man Choi, et al.
Human Vaccines & Immunotherapeutics
|
April 18, 2012
Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination
Ulrich Behre, Gerhard Bleckmann, Priya Diana Crasta, et al.
Vaccine
|
July 20, 2010
Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents
Jiri Beran, Diane Kervyn, Veronika Wertzova, et al.
Current Biology : CB
|
June 21, 2005
The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain
Simon P Reeve, Laura Bassetto, Ginka K Genova, et al.
Journal of Travel Medicine
|
March 4, 2011
Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years
Roman Chlibek, Frank von Sonnenburg, Pierre Van Damme, et al.
NPJ Vaccines
|
December 21, 2021
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen
Viki Bockstal, Auguste Gaddah, Neil Goldstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 6, 2008
Axonal injury and regeneration in the adult brain of Drosophila
Derya Ayaz, Maarten Leyssen, Marta Koch, et al.
Vaccine
|
May 4, 2010
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years
Helen Marshall, Terry Nolan, Javier Díez Domingo, et al.
The Journal of Infectious Diseases
|
October 4, 2016
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
Joanne M Langley, Naresh Aggarwal, Azhar Toma, et al.
BMC Infectious Diseases
|
December 22, 2010
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study
Pierre Van Damme, Anna Moiseeva, Igor Marichev, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Plos Biology
|
October 13, 2006
A signaling network for patterning of neuronal connectivity in the Drosophila brain
Mohammed Srahna, Maarten Leyssen, Ching Man Choi, et al.
Human Vaccines & Immunotherapeutics
|
April 18, 2012
Long-term anti-HBs antibody persistence and immune memory in children and adolescents who received routine childhood hepatitis B vaccination
Ulrich Behre, Gerhard Bleckmann, Priya Diana Crasta, et al.
Vaccine
|
July 20, 2010
Comparison of long-term (10 years) immunogenicity of two- and three-dose regimens of a combined hepatitis A and B vaccine in adolescents
Jiri Beran, Diane Kervyn, Veronika Wertzova, et al.
Current Biology : CB
|
June 21, 2005
The Drosophila fragile X mental retardation protein controls actin dynamics by directly regulating profilin in the brain
Simon P Reeve, Laura Bassetto, Ginka K Genova, et al.
Journal of Travel Medicine
|
March 4, 2011
Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years
Roman Chlibek, Frank von Sonnenburg, Pierre Van Damme, et al.
NPJ Vaccines
|
December 21, 2021
Assessments of different batches and dose levels of a two-dose Ad26.ZEBOV and MVA-BN-Filo vaccine regimen
Viki Bockstal, Auguste Gaddah, Neil Goldstein, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 6, 2008
Axonal injury and regeneration in the adult brain of Drosophila
Derya Ayaz, Maarten Leyssen, Marta Koch, et al.
Vaccine
|
May 4, 2010
Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years
Helen Marshall, Terry Nolan, Javier Díez Domingo, et al.
The Journal of Infectious Diseases
|
October 4, 2016
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
Joanne M Langley, Naresh Aggarwal, Azhar Toma, et al.
BMC Infectious Diseases
|
December 22, 2010
Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study
Pierre Van Damme, Anna Moiseeva, Igor Marichev, et al.
Page
of 4